Evidence map›Paper›PMID 38183111›Full record

ArticleJournal of translational medicine2024

Spatial features of specific CD103

Guanqun Yang, Siqi Cai, Mengyu Hu, Chaozhuo Li, Liying Yang, Wei Zhang, Jujie Sun, Fenghao Sun, Ligang Xing, Xiaorong Sun

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. CD8MedComm · 2026
    Review
  5. Review
  6. T-Cell Immunity and Lung Cancer.Respirology (Carlton, Vic.) · 2026
    Review
  7. Higher proximity of PD-L1Translational lung cancer research · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guanqun YangShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Siqi CaiShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Mengyu HuDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Chaozhuo LiDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Liying YangShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Wei ZhangDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Jujie SunDepartment of Pathology, Shandong Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China.
Fenghao SunDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Ligang XingShandong University Cancer Center, Shandong University, Jinan, Shandong, China.
Xiaorong SunShandong University Cancer Center, Shandong University, Jinan, Shandong, China. xrsun@sdfmu.edu.cn.ORCID 0000-0001-8520-9556

Funding

Department of Science & Technology of Shandong Province 2021CXGC011102National Natural Science Foundation of China 82172866National Natural Science Foundation of China 82373424Natural Science Foundation of Shandong Province ZR2019LZL019Natural Science Foundation of Shandong Province ZR2021LZL005Start-up fund of Shandong Cancer Hospital 2020PYA04
6 · The paper itself

Abstract

backgroundTissue-resident memory T (T

methodsThrough multiplex immunofluorescence (mIF) (CD8, CD103, PD-1, Tim-3, GZMB, CK), the quantity and spatial location of T

resultsThe density of T

conclusionsThese findings reveal a significant heterogeneity in the functional status and spatial distribution of T

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsCD8-Positive T-LymphocytesHepatitis A Virus Cellular Receptor 2HumansMemory T CellsPrognosisProgrammed Cell Death 1 ReceptorTumor MicroenvironmentHepatitis A Virus Cellular Receptor 2Programmed Cell Death 1 ReceptorCD103Multiplex immunofluorescenceNSCLCPrognostic biomarkerTissue-resident memory T cellTumor microenvironment

Identifiers

PMID38183111
PMCPMC10770937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.